{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:47Z","timestamp":1786980287175,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T00:00:00Z","timestamp":1420848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00508-014-0688-0","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T08:43:26Z","timestamp":1420793006000},"page":"703-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Excessive sweating induced by interaction between agomelatine and duloxetine hydrochloride: case report and review of the literature","Exzessives, durch eine Interaktion zwischen Agomelatin und Duloxetin Hydrochlorid ausgel\u00f6stes Schwitzen \u2013 Fallbericht und \u00dcbersicht \u00fcber die Literatur"],"prefix":"10.1007","volume":"127","author":[{"given":"Matej","family":"\u0160tuhec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,10]]},"reference":[{"key":"688_CR1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1358\/dot.2009.45.8.1396673","volume":"45","author":"RT Owen","year":"2009","unstructured":"Owen RT. Agomelatine: a novel pharmacological approach to treating depression. Drugs Today. 2009;45:599\u2013608.","journal-title":"Drugs Today"},{"key":"688_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4088\/JCP.09m05347blu","volume":"71","author":"S Kasper","year":"2010","unstructured":"Kasper S, Hajak G, Wulff K, et al. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline. J Clin Psychiatry. 2010;71:109\u201320.","journal-title":"J Clin Psychiatry"},{"key":"688_CR3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2165\/11593960-000000000-00000","volume":"34","author":"RH Howland","year":"2011","unstructured":"Howland RH. A benefit-risk assessment of agomelatine in the treatment of major depression. Drug Saf. 2011;34:709\u201331.","journal-title":"Drug Saf"},{"key":"688_CR4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/JCP.0b013e3181a5233f","volume":"29","author":"A Serretti","year":"2009","unstructured":"Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29:259\u201366.","journal-title":"J Clin Psychopharmacol"},{"key":"688_CR5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-0031-1297933","volume":"45","author":"C Imboden","year":"2012","unstructured":"Imboden C, Hatzinger M. Agomelatine-induced akathisia with concomitant duloxetine medication: a case report. Pharmacopsychiatry. 2012;45:162\u20133.","journal-title":"Pharmacopsychiatry"},{"key":"688_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/11539240-000000000-00000","volume":"50","author":"MP Knadler","year":"2011","unstructured":"Knadler MP, Lobo E, Chappell J, et al. Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet. 2011;50:281\u201394.","journal-title":"Clin Pharmacokinet"},{"key":"688_CR7","unstructured":"Summary of Product Characteristics. European Medicine Agency. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000915\/WC500046227.pdf . Accessed April 2014."},{"key":"688_CR8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4088\/JCP.v68n0423f","volume":"68","author":"R Mago","year":"2007","unstructured":"Mago R, Monti D. Antiadrenergic treatment of antidepressant-induced excessive sweating in 3 patients. J Clin Psychiatry. 2007;68:639\u201340.","journal-title":"J Clin Psychiatry"},{"key":"688_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00228-005-0956-z","volume":"61","author":"A Buecking","year":"2005","unstructured":"Buecking A, Vandeleur CL, Khazaal Y, et al. Mirtazapine in drug-induced excessive sweating. Eur J Clin Pharmacol. 2005;61:543\u20134.","journal-title":"Eur J Clin Pharmacol"},{"key":"688_CR10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/JCP.0b013e31818d6b67","volume":"28","author":"BY Lu","year":"2008","unstructured":"Lu BY, Cullen CE, Eide CE, et al. Antidepressant-induced sweating alleviated by aripiprazole. J Clin Psychopharmacol. 2008;28:710\u20131.","journal-title":"J Clin Psychopharmacol"},{"key":"688_CR11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"688_CR12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/JCP.0b013e3181f1f601","volume":"30","author":"CC Wu","year":"2010","unstructured":"Wu CC, Chang JP, Liou JS, et al. A case of milnacipran-related sweating alleviated by duloxetine substitution. J Clin Psychopharmacol. 2010;30:640\u20131.","journal-title":"J Clin Psychopharmacol"},{"key":"688_CR13","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.genhosppsych.2013.10.016","volume":"36","author":"M Stuhec","year":"2014","unstructured":"Stuhec M. Trimethoprim-sulfamethoxazole-related hallucinations. Gen Hosp Psychiatry. 2014;36:230.e7\u20138.","journal-title":"Gen Hosp Psychiatry"},{"key":"688_CR14","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.genhosppsych.2012.06.001","volume":"35","author":"M \u0160tuhec","year":"2013","unstructured":"\u0160tuhec M. Solifenacin-induced delirium and hallucinations. Gen Hosp Psychiatry. 2013;35:682.e3\u20134.","journal-title":"Gen Hosp Psychiatry"},{"key":"688_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00508-013-0330-6","volume":"125","author":"M \u0160tuhec","year":"2013","unstructured":"\u0160tuhec M. Duloxetine-induced life-threatening long QT syndrome. Wien Klin Wochenschr. 2013;125:165\u20136.","journal-title":"Wien Klin Wochenschr"},{"key":"688_CR16","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1345\/aph.1R522","volume":"47","author":"ML Mathys","year":"2013","unstructured":"Mathys ML, McCarrell J, Sleeper RB, Blaszczyk AT. Visual hallucinations treated with the reinitiation of memantine in a patient with Lewy body dementia. Ann Pharmacother. 2013;47:e10.","journal-title":"Ann Pharmacother"},{"key":"688_CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00508-013-0344-0","volume":"125","author":"M Stuhec","year":"2013","unstructured":"Stuhec M. Agomelatine-induced hepatotoxicity. Wien Klin Wochenschr. 2013;125:225\u20136.","journal-title":"Wien Klin Wochenschr"},{"key":"688_CR18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/JCP.0000000000000201","volume":"34","author":"M Stuhec","year":"2014","unstructured":"Stuhec M, Alisky J, Malesic I. Mirtazapine associated with drug-related thrombocytopenia: a case report. J Clin Psychopharmacol. 2014;34:662\u20134.","journal-title":"J Clin Psychopharmacol"},{"key":"688_CR19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1345\/aph.1K607","volume":"42","author":"I Kohen","year":"2008","unstructured":"Kohen I, Gampel M, Reddy L, et al. Rapidly developing hyperglycemia during treatment with olanzapine. Ann Pharmacother. 2008;42:588\u201391.","journal-title":"Ann Pharmacother"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-014-0688-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-014-0688-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-014-0688-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:58:53Z","timestamp":1559080733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-014-0688-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,10]]},"references-count":19,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s00508-014-0688-0","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,10]]}}}